A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination

Open Access

Peer-reviewed

Research Article

Dennis Morrison,

Affiliation Bio-Kinetic Clinical Applications, Springfield, Missouri, United States of America
⨯
Sandip Roy,

Affiliation Novartis Exploratory Clinical Development, Cambridge, Massachusetts, and East Hanover, New Jersey, United States of America
⨯
Craig Rayner,

Affiliation F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Basel, Switzerland
⨯
Ahmed Amer,

Affiliation Novartis Exploratory Clinical Development, Cambridge, Massachusetts, and East Hanover, New Jersey, United States of America
⨯
Dan Howard,

Affiliation Novartis Exploratory Clinical Development, Cambridge, Massachusetts, and East Hanover, New Jersey, United States of America
⨯
James R. Smith,

Affiliation F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Basel, Switzerland
⨯
Thomas G. Evans

*To whom correspondence should be addressed. E-mail: thomasg.evans@novartis.com

Affiliation Novartis Exploratory Clinical Development, Cambridge, Massachusetts, and East Hanover, New Jersey, United States of America
⨯

Reader Comments (0)

H5N1
Is the Subject Area "H5N1" applicable to this article?

Thanks for your feedback.
Influenza
Is the Subject Area "Influenza" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Influenza A virus
Is the Subject Area "Influenza A virus" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Influenza viruses
Is the Subject Area "Influenza viruses" applicable to this article?

Thanks for your feedback.